-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - ; and (2) What are the benefits and harms of using rFVIIa for selected off-label indications in patients … Current evidence of low strength is too limited to compare harms and benefits.
… Current evidence of low strength is too limited to compare harms and benefits.
… Current evidence is insufficient for comparing the harms and benefits of rFVIIa use in infant patients … Current evidence is insufficient for comparing the harms and benefits of rFVIIa use in prostatectomy.
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - ; and (2) What are the benefits and harms of using rFVIIa for selected off-label indications in patients … Current evidence of low strength is too limited to compare harms and benefits.
… Current evidence of low strength is too limited to compare harms and benefits.
… Current evidence is insufficient for comparing the harms and benefits of rFVIIa use in infant patients … Current evidence is insufficient for comparing the harms and benefits of rFVIIa use in prostatectomy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
December 16, 2011 - patients receiving treatment compared to patients receiving
routine prenatal care.
3,15
Potential harms … test properties of screening and
diagnostic tests for GDM; b) evaluate the potential benefits and harms … duration of followup
Settings: All settings
KQ2: What is the direct evidence on the benefits and harms … insulin therapy, and oral hypoglycemic agents
Comparators: Placebo or no treatment
Outcomes: Harms … KQ5 addresses harms, including anxiety, healthcare system issues, burden
on practitioner’s office,
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_research-protocol.pdf
July 21, 2014 - KQ 2: What is the evidence for harms associated with treatments for binge eating
disorder? … older) meeting criteria for LOC eating2
Interventions:
Applies only to KQs on effectiveness and harms … life: health-related quality of life or patient-reported outcomes
not otherwise listed above
• Harms … Analytic framework for binge eating disorder and loss-of-control eating:
Effectiveness and harms of … treatment harms, and costs (e.g., health
care cost and use, lost work days).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/appendicitis_research-protocol.pdf
December 09, 2013 - KQ 3:
What are the harms of diagnostic tests per se, and what are the treatment-
related harms of … Direct harms of testing (e.g., harms from exposure to ionizing radiation,
allergic reactions/kidney … of testing per se
Test-directed treatment
Harms of test directed
treatment
KQ#3# KQ#3#
KQ#1a … (e.g., change in diagnostic thinking, impact on therapeutic
decisionmaking, clinical outcomes, and harms … of testing; harms of test-directed treatment).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_executive.pdf
August 01, 2012 - We also assessed the harms of interventions,
defined by the Agency for Healthcare Research and
Quality … Key Question 5: Among adolescents and young adults
with ASD, what harms are associated with available … Finally,
interventions may be associated with harms/adverse
effects. … In addition to outcomes for treatment effectiveness and
family outcomes, we extracted data on harms/ … Only studies of medical interventions
addressed harms (Key Question 5).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-prevention-covid-surveillance-report.pdf
July 17, 2020 - Harms Limited evidence of no
difference in harms by mask
type. … • No serious harms
reported with N95
respirators and surgical
masks in randomized
controlled trials
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
January 01, 2013 - What are the adverse effects or harms associated with the treatments guided by tests of
iron status? … What are the adverse
effects or harms associated with
testing using newer and/or older
markers of … , and most studies did not attribute harms to either testing or
treatment.
1
Study Design Issues … o Most of the reported harms were attributed to iron therapy.
Key Question 3. … • Incorporates issues around both clinical benefits and potential clinical harms.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - What are the comparative harms associated with antiviral treatments?
3b. … What are the comparative harms associated with antiviral treatments?
3
3b. … What are the
comparative
harms
associated with
antiviral
treatments? … Do these harms
differ according
to patient
subgroup
characteristics? … • Incorporates issues around both clinical benefits and potential clinical harms.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/point-of-care_research.pdf
April 01, 2014 - Comparative benefits
and harms of second-generation antidepressants
in the pharmacologic treatment … Benefits and harms of pharmacologic
treatment for urinary incontinence in women: a
systematic review … Benefits and Harms of Treating Gestational
Diabetes Mellitus: A Systematic Review and
Meta-analysis … Benefits and Harms of
Treating Gestational Diabetes Mellitus: A Systematic Review and
Meta-analysis … Benefits and Harms of Treating
Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
January 01, 2011 - What are the adverse effects or harms associated with
testing using newer and/or older markers of iron … What are the adverse effects or harms associated with
the treatments guided by tests of iron status? … on harms.23,26,35,40-43 Specifically, three studies reported no
adverse events associated with iron … What are the adverse
effects or harms
associated with
testing using newer
and/or older markers
of … – Most of the reported harms were attributed to iron therapy.
Key Question 3.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
April 21, 2015 - approval of new drugs and the
availability of new evidence for efficacy, comparative effectiveness, and harms … Question 2:
What are the harms and comparative harms of newer medications for LUTS associated
with … Question 3: Do the comparative benefits and harms of newer medications for LUTS
associated with BPH … with LUTS associated with BPH
Study Objective To test the efficacy, comparative effectiveness, and harms … Study Design • Efficacy/comparative effectiveness: RCTs
Harms: RCTs and large observational studies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
July 01, 2012 - While rates of false positives and false negatives may be
directly related to adverse effects or harms … and NPV, but if no such test is available, clinicians may be interested in
the added benefits and harms … Tests that are more invasive will naturally have greater harms. … of false
positives and false negatives when assessing the harms of a diagnostic test. … The degree of harms from false positives depends on the invasiveness of further testing or
treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
June 15, 2010 - Rates of
dropouts due to harms varied from 9 to 39 percent. … Question 2:
What are the harms of each of the monotherapy or combined therapies among these adults and … How do the harms compare across different interventions? … Harms associated with any
of these interventions are evaluated in KQ2 and can include suicide, sexual … Additionally, we will evaluate studies for adequacy of collecting and reporting harms
using the McHarm
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-knee-physical-therapy_research-protocol.pdf
April 01, 2010 - regular updating of research evidence.13,21
Researchers should be able to estimate the benefits and harms … Which patient characteristics are associated with the harms of examined physical therapy
interventions … Do harms differ by the duration of the treatment and time of followup? … To assess harms of treatments we will follow the recommendations from the Methods Guide
for Comparative … harms regardless of how authors perceived causality of treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-protocol.pdf
April 19, 2023 - or models, and components to establish the state of the science of its effectiveness
and potential harms … What is the evidence of benefits and/or harms of TIC on outcomes for
patients/clients?
○ KQ 1a. … of TIC models, and organizational and practice
characteristics, are associated with benefits and/or harms … What is the evidence of benefits and/or harms of TIC on outcomes for
patients/clients?
○ KQ 2a. … engagement, trust, comfort or satisfaction,
and strengths-based outcomes (e.g., quality
of life)
Harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
September 18, 2012 - The identified harms will be characterized by using the
Common Terminology Criteria for Adverse Events … McHarm, the tool was developed from quality rating items generated by
a review of the literature on harms … • Was the mode of harms collection active (participants are asked about the occurrence of
specific … • Did study specify who collected the harms data?
• Did the study specify the timing of harms? … McMaster Quality Assessment Scale of Harms (McHarm) Quality
Assessment Scale for Primary Studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-decision-models_methods.pdf
July 01, 2012 - explore the impact of uncertainty;
make implicit assumptions clear; evaluate tradeoffs in benefits, harms … of treatment in
true positive diagnoses, avoidance of harms of treatment in true negative diagnoses … However, in other cases, harms can be induced both by the treatment and the test (e.g., if the test is … Evidence exists to estimate the benefits and harms of pharmacologic therapy in those
with and without … Decision-
analytic modeling to evaluate benefits and
harms of medical tests: uses and limitations.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-3-acute-pain.pdf
June 01, 2022 - The 2020 report
addressed benefits and harms of opioid, nonopioid pharmacologic, and nonpharmacologic … pain conditions, the report addressed the effectiveness and
comparative effectiveness (benefits and harms … harms, infections,
cardiovascular events, cognitive harms, and psychological harms (e.g., depression … harms, cardiovascular-
B-3
related harms, kidney-related harms, falls, fractures, motor vehicle … accidents,
endocrinological harms, infections, cognitive harms, and psychological harms (e.g.,
depression
-
effectivehealthcare.ahrq.gov/sites/default/files/introduction-to-user-guide-overview.pptx
January 01, 2013 - effectiveness research is the “generation and synthesis of evidence that compares the benefits and harms … effectiveness research is the “generation and synthesis of evidence that compares the benefits and harms … complex conditions)
Can lead to overuse, underuse, and off-label/risky use (unknown balance of benefits/harms … have not been rigorously studied, which could be a risky gamble since the true balance of treatment harms